Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Houston, Texas.

Dr. Peter Anton Clausen Ph.D.

Chief Operating Officer & Chief Scientific Officer

役職名	役職名
Dr. Peter Anton Clausen Ph.D.	Chief Operating Officer & Chief Scientific Officer
Mr. Joseph A. Del Guercio	Informal Board Advisor
Mr. David E. Jorden CPA	Chief Executive Officer, Chief Financial Officer, Secretary & Executive Director

Nuo Therapeutics, Inc.

Nuo Therapeutics, Inc. 経営体制

経営情報